Insulin-Like Growth Factor Binding Protein (IGFBP-1) involvement in intrauterine growth retardation: Study on IGFBP-1 overexpressing transgenic mice

Endocrinology

Volumn 147, Issue 10, 2006, Pages 4730-4737

  Ben Lagha, Nadia ^a   Seurin, Danielle ^b   Le Bouc, Yves ^b,c   Binoux, Michel ^b   Berdal, Ariane ^a,d   Menuelle, Pierrette ^a   Babajko, Sylvie ^a  

^a INSERM   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; ALIZARIN; CARBOHYDRATE; GLYCOGEN; SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ARTICLE; BIOMINERALIZATION; BODY GROWTH; BONE MINERALIZATION; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FETUS; FETUS GROWTH; GENE OVEREXPRESSION; GLYCOGEN LIVER LEVEL; HOMOZYGOSITY; INTRAUTERINE GROWTH RETARDATION; LIVER; MALE; MOUSE; NONHUMAN; OSSIFICATION; PERINATAL MORTALITY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKULL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; CALCIFICATION, PHYSIOLOGIC; CARBOHYDRATE METABOLISM; CARTILAGE; FEMALE; FETAL GROWTH RETARDATION; GENOTYPE; GROWTH; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LIVER GLYCOGEN; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; OSTEOGENESIS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOMATOMEDINS; SURVIVAL;

EID: 33748743540     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0171     Document Type: Article

References (50)

1. Yakar S, Kim H, Zhao H, Toyoshima Y, Pennisi P, Gavrilova O, Leroith D 2005 The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting. Pediatr Nephrol 20:251-254
2. Cohick WS 1993 The insulin-like growth factors. Annu Rev Physiol 55:131-153
3. Humbel RE 1990 Insulin-like growth factors I and II. Eur J Biochem 190:445-462
4. Shimasaki S, Ling N 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 3:243-266
5. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34
6. Villaudy J, Delbe J, Blat C, Desauty G, Golde A, Harel L 1991 An IGF binding protein is an inhibitor of FGF stimulation. J Cell Physiol 149:492-496
7. Butt AJ, Dickson KA, Jambazov S, Baxter RC 2005 Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells. Endocrinology 146:3113-3122
8. Ueland T 2004 Bone metabolism in relation to alterations in systemic growth hormone. Growth Horm IGF Res 14:404-417
9. Baker J, Liu JP, Robertson EJ, Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
10. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
11. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D 2002 Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781
12. Gay E, Seurin D, Babajko S, Doublier S, Cazillis M, Binoux M 1997 Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology 13:2937-2947
13. Cheng KM 1988 Hepatic glycogen metabolism in normal developing and intrauterine growth-retarded rat fetuses. Nippon Sanka Fujinka Gakkai Zasshi 40:781-788
14. Styne DM 1998 Fetal growth. Clin Perinatol 25:917-938
15. McLeod MJ 1980 Differential staining of cartilage and bone in whole tissue fetuses by alcian blue and alizarin red S. Teratology 22:299-301
16. Ben Lagha N, Menuelle P, Seurin D, Binoux M, Lebouc Y, Berdal A 2002 Bone formation in the context of growth retardation induced by hIGFBP-1 overexpression in transgenic mice. Connect Tissue Res 43:515-519
17. Van Handel E 1965 Estimation of glycogen in small amounts of tissue. Anal Biochem 11:256-271
18. Seifter J 1950 Studies on the pharmacology and toxicology of testicular hyaluronidase. Ann NY Acad Sci 52:1141-1155
19. Seurin D, Froment P, Bluet-Pajot MT, Epelbaum J, Monget P, Binoux M 2002 Functional alteration of the somatotrophic axis in transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. Pediatr Res 52:168-174
20. Dai Z, Xing Y, Boney C, Clemmons DR, D'Ercole AJ 1994 Human insulin-like growth factor-binding protein-1 (hIGFP-1) in transgenic mice: characterization and insights into the regulation of IGFBP-1 expression. Endocrinology 135:1316-1327
21. Rajkumar K, Barron D, Lewitt MS, Murphy LJ 1995 Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 136:4029-4034
22. Crossey PA, Jones JS, Miell JP 2000 Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 49:457-465
23. Watson CS, Bialek P, Anzo M, Khosravi J, Yee SP, Han VK 2006 Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction. Endocrinology 147:1175-1186
24. Ganrot PO, Bjerre B 1967 α-1-Antitrypsin and α-2- macroglobulin concentration in serum during pregnancy. Acta Obstet Gynecol Scand 46:126-137
25. Girard J 1990 Metabolic adaptations to change of nutrition at birth. Biol Neonate 58:3-15
26. Kajimura S, Aida K, Duan C 2005 Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc Natl Acad Sci USA 102:1240-1245
27. de Zegher F, Francois I, van Helvoirt M, Van den Berghe G 1997 Clinical review 89: small as fetus and short as child: from endogenous to exogenous growth hormone. J Clin Endocrinol Metab 82:2021-2026
28. Hoeflich A, Wu M, Mohan S, Foll J, Wanke R, Froehlich T, Arnold GJ, Lahm H, Kolb HJ, Wolf E 1999 Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140:5488-5496
29. Murphy LJ, Molnar P, Lu X, Huang H 1995 Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J Mol Endocrinol 15:293-303
30. Salih DA, Tripathi G, Holding C, Szestak TA, Gonzalez MI, Carter EJ, Cobb LJ, Eisemann JE, Pell JM 2004 Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci USA 101:4314-4319
31. Bienvenu G, Seurin D, Grellier P, Froment P, Baudrimont M, Monget P, Le Bouc Y, Babajko S 2004 Insulin-like growth factor binding protein-6 transgenic mice: postnatal growth, brain development, and reproduction abnormalities. Endocrinology 145:2412-2420
32. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-2682
33. Wang J, Zhou J, Bondy CA 1999 Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J 13:1985-1990
34. 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab 86:2484-2493
35. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
36. DeChiara TM, Efstratiadis A, Robertson EJ 1990 A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78-80
37. DeChiara TM, Robertson EJ, Efstratiadis A 1991 Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64:849-859
38. Eckstein F, Pavicic T, Nedbal S, Schmidt C, Wehr U, Rambeck W, Wolf E, Hoeflich A 2002 Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice. Anat Embryol 206:139-148
39. Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL 2003 Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 18:836-843
40. Devlin RD, Du Z, Buccilli V, Jorgetti V, Canalis E 2002 Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia. Endocrinology 143:3955-3962
41. Unterman T, Lacson R, Gotway MB, Oehler D, Gounis A, Simmons RA, Ogata ES 1990 Circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) and hepatic mRNA are increased in the small for gestational age (SGA) fetal rat. Endocrinology 127:2035-2037
42. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M 1991 Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationship with growth in normal subjects and in subjects with intra-uterine growth retardation. Pediatr Res 29:219-225
43. Chard T 1994 Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul 4:91-100
44. Boyne MS, Thame M, Bennett FI, Osmond C, Miell JP, Forrester TE 2003 The relationship among circulating insulin-like growth factor (IGF)-I, IGF-binding proteins-1 and -2, and birth anthropometry: a prospective study. J Clin Endocrinol Metab 88:1687-1691
45. Verhaeghe J, Van Herck E, Billen J, Moerman P, Van Assche FA, Giudice LC 2003 Regulation of insulin-like growth factor-I and insulin-like growth factor binding protein-1 concentrations in preterm fetuses. Am J Obstet Gynecol 188:485-491
46. Crossey PA, Pillai CC, Miell JP 2002 Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 110:411-418
47. Namgung R, Tsang RC, Specker BL, Sierra RI, Ho ML 1993 Reduced serum osteocalcin and 1,25-dihydroxyvitamin D concentrations and low bone mineral content in small for gestational age infants: evidence of decreased bone formation rates. J Pediatr 122:269-275
48. Namgung R, Tsang RC 2000 Factors affecting newborn bone mineral content: in utero effects on newborn bone mineralization. Proc Nutr Soc 59:55-63
49. Van Erum R, Mulier M, Carels C, de Zegher F 1998 Short stature of prenatal origin: craniofacial growth and dental maturation. Eur J Orthod 20:417-425
50. Barker DJ 2002 Fetal programming of coronary heart disease. Trends Endocrinol Metab 13:364-368